Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations Authors
Received: 15 March 1987 Revised: 15 October 1987 Accepted: 15 October 1987 DOI:
10.1007/BF01966429 Cite this article as: Whitehead, A.M. Pharmaceutisch Weekblad Scientific Edition (1988) 10: 12. doi:10.1007/BF01966429 Abstract
in vitro study of currently available pancreatic enzyme preparations was carried out to compare the three main types of product available, these being simple pancreatin preparations, enteric coated tablets and enteric coated granules. Two products from each of these types were analysed to compare their enzyme contents. The enteric coated preparations were tested for acid resistance and their pH dissolution profiles were also investigated. The measured enzyme contents were generally higher than the declared values but products' enzyme declarations remain valid for comparison. As the BP declaration for protease does not include total protease this value may be misleading. Acid resistance and pH dissolution profiles varied both between the types of preparation and between the actual products tested. The enteric coated granule preparations were more resistant to acid and released their enzyme more rapidly once the pH threshold of dissolution was reached. Of the two enteric coated granule preparations, Creon (Duphar) was more resistant to acid and released its enzyme from a slightly lower pH value. Key words Acid resistance Amylases Dissolution Drug compounding Enzyme activity Lipase Pancreatin Peptide hydrolases References
Hodson ME. Cystic fibrosis. Postgrad Med J 1984;60:225–33.
Anonymous. 1974 Report on survival studies of patients with cystic fibrosis. Atlanta: Cystic Fibrosis Foundation, 1976.
Lankisch PG. Progress report. Exocrine pancreatic function tests. Gut 1982;23:777–98.
Temperley JM. Clinical aspects of pancreatic disease. Update 1984;(August):169–80.
Anonymous. Pancreatic extracts [Editorial]. Lancet 1977;2:73–4.
Lapey A, Kattwinkel J, Di Sant'Agnese PA, Lester L. Steatorrhoea and azotorrhoea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis. J Pediatr 1974;84:328–32.
Goodchild MC, Segaro E, Brown GA, Cruchley PM, Jukes HR, Anderson CM. Comparative trial of Pancrex v forte and Nutrizym in treatment of malabsorption in cystic fibrosis. Br Med J 1974;3:712–4.
Graham DY. Pancreatic enzyme replacement. The effect of antacids or cimetidine. Dig Dis Sci 1982;27:485–90.
DiMagno EP. Controversies in the treatment of exocrine pancreatic insufficiency. Dig Dis Sci 1982;27:481–4.
Northfield T, Zentler-Munro P, Fine P. Mechanisms and management of pancreatic steatorrhoea. Update 1984;(June):489–99.
Meyer JH. The ins and outs of oral pancreatic enzymes. N Engl J Med 1977;296:134–5.
Abrahams CK, Hamosh M, Hubbard VS, Dutta SK, Hamosh P. Lingual lipase in cystic fibrosis. J Clin Invest 1984;73:374–83.
DiMagno EP, Malagelada JR, Go VLW, Moertel CG. Fate of orally ingested enzymes in pancreatic insufficiency: Comparison of two dosage schedules. N Engl J Med 1977;297:854–8.
Iber FL, Heizer WD. Gastric inactivation of pancreatic enzyme supplements. Clin Res 1963;11:397.
Graham DY. Relation between
enzyme activities and
potency in commercial pancreatic extracts. N Engl J Med 1977;296:1314–7.
Ruyssen R, Lauwers A. Pharmaceutical enzymes. Gent: E Story Scientia, 1978:57–84.
Anonymous. British Pharmacopoeia 1980. Vol. 1. London: Her Majesty's Stationery Office, 1980:324.
Anonymous. British Pharmacopoeia 1980. Vol. 11. London: Her Majesty's Stationery Office, 1980:574.
Anonymous. British Pharmacopoeia 1980. Vol. 11. Appendix XIV. London: Her Majesty's Stationery Office, 1980: A149.
Anonymous. British Pharmacopoeia 1980. Addendum 1982, Appendix XIV K. London: Her Majesty's Stationery Office, 1982:A17.
Anonymous. British Pharmacopoeia 1980. Addendum 1986, Appendix XIV. London: Her Majesty's Stationery Office, 1986:A103.
Anonymous. British Pharmacopoeia 1980. Vol. 11. Appendix XII. A. London: Her Majesty's Stationery Office, 1980:A113–4.
Dutta SK, Russel RM, Iber FL. Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Dig Dis Sci 1979;24:529–34.
CrossRef PubMed Copyright information
© Bohn, Scheltema & Holkema 1988